Annual Net Income
$132.33 M
+$178.74 M+385.14%
December 31, 2023
Summary
- As of February 7, 2025, VYGR annual net profit is $132.33 million, with the most recent change of +$178.74 million (+385.14%) on December 31, 2023.
- During the last 3 years, VYGR annual net income has risen by +$95.59 million (+260.17%).
- VYGR annual net income is now at all-time high.
Performance
VYGR Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
-$9.04 M
+$1.10 M+10.82%
September 30, 2024
Summary
- As of February 7, 2025, VYGR quarterly net profit is -$9.04 million, with the most recent change of +$1.10 million (+10.82%) on September 30, 2024.
- Over the past year, VYGR quarterly net income has dropped by -$65.44 million (-116.04%).
- VYGR quarterly net income is now -107.29% below its all-time high of $124.04 million, reached on March 31, 2023.
Performance
VYGR Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
$25.88 M
+$16.86 M+186.82%
September 30, 2024
Summary
- As of February 7, 2025, VYGR TTM net profit is $25.88 million, with the most recent change of +$16.86 million (+186.82%) on September 30, 2024.
- Over the past year, VYGR TTM net income has dropped by -$106.45 million (-80.44%).
- VYGR TTM net income is now -80.44% below its all-time high of $132.33 million, reached on December 31, 2023.
Performance
VYGR TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
VYGR Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +385.1% | -116.0% | -80.4% |
| 3 y3 years | +260.2% | +61.7% | +155.8% |
| 5 y5 years | +249.9% | +61.7% | +155.8% |
VYGR Net Income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +285.9% | -107.3% | +65.1% | -80.4% | +136.3% |
| 5 y | 5-year | at high | +285.9% | -107.3% | +70.0% | -80.4% | +127.9% |
| alltime | all time | at high | +249.9% | -107.3% | +70.0% | -80.4% | +127.1% |
Voyager Therapeutics Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$9.04 M(-10.8%) | $25.88 M(+186.8%) |
| Jun 2024 | - | -$10.14 M(-10.5%) | $9.02 M(-396.4%) |
| Mar 2024 | - | -$11.33 M(-120.1%) | -$3.04 M(-102.3%) |
| Dec 2023 | $132.33 M(-385.1%) | $56.40 M(-317.7%) | $132.33 M(+153.0%) |
| Sep 2023 | - | -$25.90 M(+16.6%) | $52.31 M(-45.4%) |
| Jun 2023 | - | -$22.21 M(-117.9%) | $95.83 M(-3.2%) |
| Mar 2023 | - | $124.04 M(-625.0%) | $98.95 M(-313.2%) |
| Dec 2022 | -$46.41 M(-34.8%) | -$23.63 M(-234.1%) | -$46.41 M(+171.8%) |
| Sep 2022 | - | $17.62 M(-192.3%) | -$17.07 M(-71.5%) |
| Jun 2022 | - | -$19.09 M(-10.5%) | -$59.83 M(-15.6%) |
| Mar 2022 | - | -$21.32 M(-473.4%) | -$70.87 M(-0.5%) |
| Dec 2021 | -$71.20 M(-293.8%) | $5.71 M(-122.7%) | -$71.20 M(-23.3%) |
| Sep 2021 | - | -$25.14 M(-16.5%) | -$92.83 M(-618.2%) |
| Jun 2021 | - | -$30.12 M(+39.1%) | $17.92 M(-54.5%) |
| Mar 2021 | - | -$21.65 M(+35.9%) | $39.35 M(+7.1%) |
| Dec 2020 | $36.74 M(-184.3%) | -$15.93 M(-118.6%) | $36.74 M(-8.4%) |
| Sep 2020 | - | $85.61 M(-1086.2%) | $40.09 M(-166.2%) |
| Jun 2020 | - | -$8.68 M(-64.2%) | -$60.52 M(+48.7%) |
| Mar 2020 | - | -$24.26 M(+93.0%) | -$40.69 M(-6.7%) |
| Dec 2019 | -$43.60 M | -$12.57 M(-16.2%) | -$43.60 M(-18.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2019 | - | -$15.01 M(-234.5%) | -$53.55 M(-9.0%) |
| Jun 2019 | - | $11.15 M(-141.0%) | -$58.84 M(-38.4%) |
| Mar 2019 | - | -$27.17 M(+20.6%) | -$95.53 M(+8.2%) |
| Dec 2018 | -$88.29 M(+24.9%) | -$22.53 M(+11.1%) | -$88.29 M(+13.8%) |
| Sep 2018 | - | -$20.29 M(-20.6%) | -$77.58 M(-3.8%) |
| Jun 2018 | - | -$25.54 M(+28.2%) | -$80.64 M(+9.0%) |
| Mar 2018 | - | -$19.93 M(+68.5%) | -$73.98 M(+4.6%) |
| Dec 2017 | -$70.70 M(+75.9%) | -$11.83 M(-49.3%) | -$70.70 M(-3.9%) |
| Sep 2017 | - | -$23.35 M(+23.7%) | -$73.54 M(+24.2%) |
| Jun 2017 | - | -$18.88 M(+13.4%) | -$59.19 M(+19.2%) |
| Mar 2017 | - | -$16.65 M(+13.5%) | -$49.65 M(+23.5%) |
| Dec 2016 | -$40.19 M(+35.5%) | -$14.67 M(+63.1%) | -$40.19 M(+22.5%) |
| Sep 2016 | - | -$9.00 M(-3.6%) | -$32.80 M(+18.3%) |
| Jun 2016 | - | -$9.34 M(+29.9%) | -$27.72 M(+24.4%) |
| Mar 2016 | - | -$7.19 M(-1.3%) | -$22.28 M(-24.9%) |
| Dec 2015 | -$29.67 M(+81.8%) | -$7.28 M(+85.9%) | -$29.67 M(+9.6%) |
| Sep 2015 | - | -$3.92 M(+0.6%) | -$27.08 M(-0.3%) |
| Jun 2015 | - | -$3.90 M(-73.3%) | -$27.17 M(+16.7%) |
| Mar 2015 | - | -$14.58 M(+210.8%) | -$23.27 M(+167.6%) |
| Dec 2014 | -$16.32 M | -$4.69 M(+17.1%) | -$8.70 M(+117.1%) |
| Sep 2014 | - | -$4.00 M | -$4.00 M |
FAQ
- What is Voyager Therapeutics annual net profit?
- What is the all time high annual net income for Voyager Therapeutics?
- What is Voyager Therapeutics annual net income year-on-year change?
- What is Voyager Therapeutics quarterly net profit?
- What is the all time high quarterly net income for Voyager Therapeutics?
- What is Voyager Therapeutics quarterly net income year-on-year change?
- What is Voyager Therapeutics TTM net profit?
- What is the all time high TTM net income for Voyager Therapeutics?
- What is Voyager Therapeutics TTM net income year-on-year change?
What is Voyager Therapeutics annual net profit?
The current annual net income of VYGR is $132.33 M
What is the all time high annual net income for Voyager Therapeutics?
Voyager Therapeutics all-time high annual net profit is $132.33 M
What is Voyager Therapeutics annual net income year-on-year change?
Over the past year, VYGR annual net profit has changed by +$178.74 M (+385.14%)
What is Voyager Therapeutics quarterly net profit?
The current quarterly net income of VYGR is -$9.04 M
What is the all time high quarterly net income for Voyager Therapeutics?
Voyager Therapeutics all-time high quarterly net profit is $124.04 M
What is Voyager Therapeutics quarterly net income year-on-year change?
Over the past year, VYGR quarterly net profit has changed by -$65.44 M (-116.04%)
What is Voyager Therapeutics TTM net profit?
The current TTM net income of VYGR is $25.88 M
What is the all time high TTM net income for Voyager Therapeutics?
Voyager Therapeutics all-time high TTM net profit is $132.33 M
What is Voyager Therapeutics TTM net income year-on-year change?
Over the past year, VYGR TTM net profit has changed by -$106.45 M (-80.44%)